Amoebiasis is one of the most important infectious diseases afflicting mainly tropical and subtropical countries. This study was carried out in the Sharjah Emirate, UAE in order to accurately detect and differentiate Entamoeba histolytica, Entamoeba dispar and E. moshkovskii in fecal samples collected from the Sharjah municipality public health clinic by ELISA and nested polymerase chain reaction (PCR). One hundred and twenty specimens were examined and the PCR was positive for E. histolytica, E. dispar and E. moshkovskii (collectively referred to as Entamoeba complex) in 19.2% (23 out of 120). Of those, 10% (12/120) were mono -infection with E. histolytica; 2.5% (3/120) with E. dispar; and 2.5% (3/120) E. moshkovskii. The nested PCR also detected mixed infections by both E. histolytica and E. dispar in 3.3% (4/120) and E. dispar and E. moshkovskii in 0.8% (1/120). The TechLab ELISA kit failed to detect E. histolytica in any of the E. histolytica PCR positive samples. Overall, the percentage of E. histolytica including those found in mixed infections was 13.3% (16/120). Compared to nested PCR, microscopy was found to have an overall sensitivity of 52.2% and a specificity of 75.2% for detection of Entamoeba complex. The present study indicates that E. histolytica is present in the UAE with an average incidence rate of 13.3%. However, larger studies need to be conducted in order to confirm these findings. We propose the use of PCR in both the routine diagnosis of amoebiasis and epidemiological survey in the UAE.
Introduction
Entamoeba histolytica is a gut dwelling protozoan parasite that causes intestinal amoebiasis and amoebic liver abscess (ALA) worldwide (Walsh 1986 ). The disease amoebiasis still remains a major cause of morbidity and mortality in the developing world (Mortimer and Chadee 2010; Ravdin 1995) . It is well established that about 500 million individuals are infected globally each year, resulting in up to 100,000 deaths annually (W.H.O. 1997) . With the occurrence of two other non-pathogenic species of Entamoeba namely E. dispar (W.H.O. 1997 ) and E. moshkovskii , the pathogenic E. histolytica is often inaccurately reported or diagnosed. Still the only tool used for the detection of E. histolytica in most countries, light microscopy, cannot distinguish between the morphologically identical yet genetically distinct three species of Entamoeba. Consequently, it is now believed that epidemiological figures on the disease and its spread are overemphasized since they relied on microscopic identification only (Ali et al. 2008) . There is, therefore, a need to identify E. histolytica accurately using more specific and sensitive tools.
Various types of serological assays such as gel diffusion precipitation test and enzyme-linked immunosorbent assay (ELISA) have been used to distinguish between E. histolytica and E. dispar. They were nevertheless, found to be inadequate in highly endemic regions and new detection methodologies such as antigen detection ELISA and polymerase chain reaction (PCR) have since been developed Othman et al. 2010; Ackers 2002; Tanyuksel and Petri 2003 (Haque et al. 1998; Stark et al. 2008) . Many outstanding PCR assays for the specific detection and differentiation of E. histolytica, E. dispar and E. moshkovskii DNA in fecal specimens are available (Gutierrez-Cisneros et al. 2010; Haque et al. 2010; Paul et al. 2007; Tanyuksel and Petri 2003) . Recently though, a multiplex nested PCR method targeting the 16S-like rRNA gene for the instant detection and differentiation of E. histolytica, E. dispar and E. moshkovskii directly in fecal samples has been developed by Khairnar and Parija (2007) .
Few studies have investigated the prevalence of amoebiasis in the Arabian Gulf countries. However, data obtained were based on microscopic identification of cysts and/or trophozoites of E. histolytica/E. dispar only. A 2007 study on intestinal parasites occurrence in stools using the direct smear technique and the formol ether concentration method from residents in the Southwestern region of Saudi Arabia showed a high prevalence of intestinal parasitic infections (70.5%). E. histolytica/E. dispar and G. lamblia were found to be the most common intestinal parasites. The infection rate was found to be higher in the less-than-30 age group (74.8%) (AlHarthi and Jamjoom 2007). Nonetheless, a recent study carried out in Jeddah City, Saudi Arabia, reported a prevalence of 2.7% of E. histolytica infections using TechLab E. histolytica II Kits (Barnawi et al. 2007) . A more recent study conducted in the Sharjah Emirate, United Arab Emirates (UAE) reported an E. histolytica prevalence of 72% among both expatriates and native Emirati people attending hospitals of the country. In their study, the researchers considered all pathogenic amoebas as E. histolytica based on the microscopic features and did not differentiate it from E. dispar nor E. moshkovskii (Dash et al. 2010 ) . To our knowledge however, no study using molecular identification techniques to determine the true prevalence and epidemiology of E. histolytica in the UAE, particularly in Sharjah has been conducted. Therefore, in this study we aimed to accurately detect and differentiate E. histolytica, E. dispar and E. moshkovskii DNA in fecal samples using nested PCR and compare it to the Entamoeba histolytica II ELISA detection kit of Techlab (Blacksburg, USA); an antigen capture assay that has been shown to be highly specific for E. histolytica.
Materials and methods

Samples and microscopic examination
Stool samples were collected from the Sharjah Municipality Public Health Clinic (SMPHC) between June 2009 and January 2011. In total 120 specimens were collected from asymptomatic individuals presenting to the SMPHC for intestinal parasites screening. Both saline and iodine wet mounts of fresh unpreserved stool samples were examined microscopically for demonstrating E. histolytica/E. dispar/E. moshkovskii complex cysts and trophozoites as described by Parija and Prabhakar (1995) . Briefly, saline wet mounts were made by mixing approximately 2 mg of stool with a drop of physiological saline on a glass microscope slide and placing a cover slip over the stool suspension. Likewise, iodine wet mounts were prepared by adding approximately 2 mg of stool to a drop of Lugol's iodine on a glass microscope slide and placing a cover slip on the stool suspension. The wet mounts were microscopically examined initially by using a low-power (×10) objective and then using a high-power (×40) objective of a compound light microscope. Each stool sample was screened by experienced microscopists before reporting negative results. The samples, in sterile capped containers, were then transported without delay to the University of Sharjah where aliquots of fresh, unpreserved stool samples were stored at -20°C until used for PCR and ELISA tests.
Antigen detection ELISA
The fecal samples were tested for E. histolytica using the E. histolytica II ELISA antigen detection kit (TechLab, Inc. Blacksburg, VA, USA) as per the manufacturer's instructions. The optical densities (OD) were read at 450 nm using Biotek ELx808 reader (Winooski, VT, USA) and a sample was considered positive if the difference of OD between the test and the negative control was more than 0.05.
DNA extraction
DNA was extracted from all fecal samples using the QIAamp stool DNA Mini Kit (Qiagen GmbH, Hilden, Germany) as per the manufacturer's recommendations. DNA samples were stored at -20°C until analyzed.
PCR detection of E. histolytica, E. dispar and E. moshkovskii
The nested PCR conditions were performed as described by Khairnar and Parija (2007) , with slight modifications. Different species specific product sizes for E. histolytica, E. dispar and E. moshkovskii were distinguished (Khairnar and Parija 2007) . The PCR amplification reaction was performed in a total volume of 25 μl in 0.2-ml PCR tubes using Master cycler gradient (Eppendorf; Hamburg, Germany). Briefly, the reaction mixture contained 2.5 μl of 10x PCR buffer with 15mM MgCl 2 , 0.5 μl of dNTP mix (100 mM each), 0.5 μl (5u/μl) of Taq polymerase (Promega; Madison, WI, USA), 0.5 μl of each species specific primer (25 ρmol each) and 1.5 μl of the extracted DNA solution. Amplification of the Entamoeba genus fragment started with an initial denaturation at 95°C for 2 minutes, followed by 30 cycles of denaturation at 92°C for 1 minute, 56°C for 1 minute (annealing), and 72°C for 1 minute (extension), with a final extension cycle of 7 minutes at 72°C.
One microlitre of the first PCR product was used as a template in the nested (species specific) PCR reaction. The nested PCR was performed as described above, except, the annealing temperature was changed to 52°C. All other parameters of the Entamoeba in the UAE 187 amplification cycle remained unchanged. Amplified products were stained with ethidium bromide after electrophoresis on a 1.2% agarose gel. Positive and negative controls were included with each batch of samples analyzed. To rule out the possibility of negative nested PCR results due to PCR inhibitors in faecal samples, the DNA of negative control stool samples was spiked with the standard DNA of Entamoeba followed by nested PCR amplification.
Results
In the current study 120 fecal specimens were included in the study sample to detect and differentiate between E. histolytica, E. dispar and E. moshkovskii using antigen detection by ELISA and PCR. All were from asymptomatic individuals screened for intestinal parasites as part of routine check-ups. Vegetative and/or cyst forms of E. histolytica/E. dispar/ E. moshkovskii complex were found in 36/120 (30%) by direct wet mount microscopy ( Table I) .
As for the nested PCR amplification, species-specific diagnostic fragments of 439 bp, 174 bp and 553 bp were obtained for all three Entamoeba species namely E. histolytica, E. dispar and E. moshkovskii, respectively. The nested PCR was performed separately on all 120 fecal samples for E. histolytica/E. dispar/E. moshkovskii. E. histolytica/E. dispar/E. moshkovskii complex was detected in 23/120 (19.2%) of the fecal samples. Of these, 10% (12/120) were mono-infections with E. histolytica; 2.5% (3/120) with E. dispar; and 2.5% (3/120) E. moshkovskii. The nested PCR also detected mixed infections by both E. histolytica and E. dispar in 3.3% (4/120) and E. dispar and E. moshkovskii in 0.8% (1/120) of the tested fecal samples (Table II) . Overall, the percentage of E. histolytica in tested fecal samples including those found in mixed infections was 13.3% (16/120), E. dispar including those found in mixed infections was 6.7% (8/120), and E. moshkovskii including those found in mixed infections was 3.3% (4/120). The PCR was positive in 12 out of 36 fecal samples reported positive for E. histolytica/E. dispar/E. moshkovskii complex trophozoites and/or cysts by microscopy. The detection of Entamoeba complex infection with microscopy was compared to nested PCR in all samples tested. The sensitivity and specificity of microscopy were 52.2% and 75.2%, respectively.
Worthy of note was the antigen detection ELISA; E. histolytica adhesin antigen was not detected in any of the tested samples; the kit failed to detect any of the 16 PCR positive E. histolytica samples including those with mixed infections (0/16).
Discussion
Each year 34-50 million symptomatic cases of amoebiasis occur with up to 100,000 patients dying annually as a result of complications (W.H.O. 1997). Most E. histolytica infections are asymptomatic; however few strains of E. histolytica may invade the intestinal wall resulting in amoebic colitis or extraintestinal diseases such as ALA (Fotedar et al. 2007 ). Despite its inability to distinguish and differentiate E. histolytica from the morphologically identical nonpathogenic species E. dispar and E. moshkovskii, microscopy has always been used to diagnose E. histolytica in fecal samples. This has resulted in the unnecessary treatment of a large number of individuals with anti-amoebic drugs as well as providing an inaccurate picture of the epidemiology of the organism and the disease since previous amplified data relied inaccurately on microscopy only (Kebede et al. 2004 ). At present, there are many new diagnostic kits available which surpass the identification of these protozoa by microscopy leading to precise diagnosis. The antigen-based ELISA and PCR are two such techniques reported to demonstrate exceptional sensitivities and specificities when compared with microscopy (Haque et al. 1998; Tanyuksel and Petri 2003) . This research paper, the first of its kind in the UAE, was designed to detect and differentiate the three species of Entamoeba (E. histolytica, E. dispar and E. moshkovskii) using the nested PCR method described by Khairnar and Parija (2007) directly from fecal samples. Moreover, another objective of this work was to reveal the rate of infection of each one of them. In our study, the rate of infection with E. histolytica (both mono-and mixed infections) was found to be 13.3% (16/120). Despite the limited size of our study sample, the low rate obtained was similar to those found elsewhere. For instance, in a study in Vietnam on asymptomatic adults, E. histolytica was identified in 11.2% using the PCR method (Blessmann et al. 2003) . A study of a larger population may nevertheless, give a clear picture of the prevalence of E. histolytica in the UAE. The study also detected mono-infections with E. dispar and E. moshkovskii. Both showed an infection rate of 2.5%. Multiple infections, despite lower than in other studies, were also noted with E. histolytica and E. dispar having an infection rate of 3.3% compared to E. dispar and E. moshkovskii 0.8% (Nunez et al. 2001; Parija and Khairnar 2005) . A point worth mentioning here is that neither double nor triple infections of (E. histolytica and E. moshkovskii) and (E. histolytica, E. dispar and E. moshkovskii), respectively, were detected in this work. At this stage, we feel that this may be due to the small number of samples investigated in our study.
Although the TechLab Entamoeba histolytica II kit has been evaluated previously in different settings (endemic and non-endemic) to detect E. histolytica, we believe that this is the first study to compare it with the nested PCR in the UAE. We found that TechLab Entamoeba histolytica II kit performed poorly when compared to the nested PCR. The kit failed to identify any of the PCR positive E. histolytica fecal samples. Our results were comparable to other studies carried out in low-endemicity regions (Gonin and Trudel 2003; Visser et al. 2006) . Moreover, an Australian study compared two stool antigen detection kits (CELISA PATH and TechLab E. histolytica II ELISA) with PCR for the diagnosis of E. histolytica infections. For fecal samples that were microscopy positive for Entamoeba complex, the TechLab E. histolytica II kit failed to detect any (0/18) of the PCR-positive samples. A sensitivity and specificity of 0% and 100%, respectively in comparison to PCR was thus reported for the TechLab E. histolytica II ELISA kit (Stark et al. 2008) . On the other hand, an Ecuadorian study conducted in an E. histolytica endemic area north of the country, reported a sensitivity of 14.3% and a specificity of 98.4% when compared to isoenzyme analysis. This sensitivity is rather poor for the TechLab E. histolytica II ELISA kit considering that this region of the Ecuador is known for its high endemicity (Gatti et al. 2002) . The results that we obtained, together with other groups, using the TechLab E. histolytica II ELISA kit are clearly incompatible with results obtained in countries where E. histolytica is highly endemic in which high sensitivities (95%-100%) were documented (Haque et al. 1995 (Haque et al. , 1997 Solaymani-Mohammadi et al. 2006) . We are unable to explain why this is so; however, along with other groups, we believe this might be due to the low antigen level in the fecal samples, which is much less than the detection limit of the kit (Mirelmann et al. 1997) . Another reason attributed to the poor performance of the TechLab E. histolytica II ELISA kit is the fact that the assay recognizes the vegetative forms adhesin only, normally present in diarrheal fecal specimens during an acute amoebic infection and not the cyst stage (Gatti et al. 2002) . Yet, in a study by Stark et al. (2008) , where at least half of the patients were symptomatic and in the majority of the cases both trophozoites and cysts were present, ELISA kits still performed poorly. In addition, polymorphism in the lectin antigen used in the E. histolytica II ELISA may also explain the failure of this test (Beck et al. 2002) . All fecal samples in our study were from asymptomatic individuals. Samples from symptomatic diarrheal patients will be assayed in the future to determine the suitability of the ELISA kit for the detection of E. histolytica infections.
The study also highlights the trouble many laboratory technicians face in identifying and differentiating morphologically similar cysts and/or trophozoites of Entamoeba complex and other amoeba species (such as E. hartmanni and E. coli) microscopically. Approximately half of the samples reported positive by microscopy for Entamoeba complex trophozoites and/or cysts were found to be negative by nested PCR (false positive). On the other hand, few of the negatively reported were actually positive for E. histolytica by PCR. This finding raises concern about the skill of the technician, workload, and the time spent on each slide. All three may have grave end results. A 1991 study in Managua, Nicaragua recognized this problem; 71% of the "intestinal amoebiasis cases" lacked diagnostic basis and the authors suggested that "intestinal amoebiasis" was being overdiagnosed (López et al. 1991) .
In conclusion, our results provide important data for the public health care system in the UAE as this is the first time the species of E. histolytica/E. dispar/E. moshkovskii complex have been distinguished by molecular tools. We have shown the infection rate with E. histolytica (pathogenic) to be 13.3%. Moreover, our study clearly demonstrates the advantages of PCR over ELISA-based kits and microscopy in both sensitivity and specificity. Recently, a possible association between the nonpathogenic E. moshkovskii and disease in young children and in the experimental mice has been reported by Shimokawa et al. (2012) thus further emphasizing the need of specific diagnosis of E. histolytica, E. dispar and E. moshkovskii by molecular techniques. Therefore, we believe that all detection and differentiation of Entamoeba spp. should be performed by PCR. Nevertheless, we feel that more samples Entamoeba in the UAE 189 need to be tested to more accurately determine E. histolytica prevalence in the country.
